How long does an “original” drug patent last?
In the U.S., the length of patent protection for a brand-name (“original”) drug is typically tied to a filing-based timeline. A utility patent generally lasts 20 years from the date the patent application is filed, assuming required fees are paid and the patent stays valid. That 20-year term is counted from the earliest filing date in the patent family, not from the date the drug is approved or launched.
Does FDA approval extend the effective time a company has the drug on the market?
Drugmakers often get extra time beyond the basic patent term through two main mechanisms:
- Patent term adjustments (PTA): The FDA review process can lengthen the patent term for the patent covering the drug product, due to delays in the patent office process.
- Exclusivity protections (not the same as a patent): Even after a patent expires, certain regulatory exclusivities can still block competitors from marketing a generic or biosimilar for a set period.
Because the drug approval process takes years, the practical “time left” after launch can be shorter than 20 years, even though the patent term itself is still counted from filing.
What happens if a patent expires before exclusivity ends?
If the drug’s patent protection ends, a generic or biosimilar manufacturer may still be blocked from marketing depending on whether exclusivity is still in force for the reference product. Once both patent barriers and applicable exclusivities are gone, competition can usually begin.
How long is it in practice for a typical brand-name drug?
Companies usually get less than 20 years of market exclusivity from the patent term because patents start counting years before FDA approval. The exact result varies by when the patent was filed relative to development and approval, plus any PTA and any regulatory exclusivity period.
If you want, share the drug name (or active ingredient) and country, and the time window can be checked more precisely (including the relevant patents and exclusivity status).